Amrize reported second-quarter 2026 adjusted earnings per share (EPS) of $0.88, missing the analyst consensus estimate of $0.94 by 6.38%. Despite the earnings miss, the company delivered a revenue beat, with sales rising 8.51% year-on-year to $3.494 billion, surpassing the $3.365 billion expectation by 3.83%. The divergence between top-line strength and bottom-line pressure highlights the impact of rising input costs on profitability, even as robust demand from data centers and energy infrastructure projects supported volume growth.

The filing was made pursuant to Article 53 LR regulations. Jan Jenisch, Chairman and CEO, attributed the revenue performance to Amrize’s strategic footprint and network strength. While net income rose 14.4% to $476 million compared to $416 million in the prior-year period, the adjusted EPS figure of $0.88 fell short of market expectations. The company returned $502 million to shareholders through dividends and share repurchases during the quarter.

Segment Performance and Cost Pressures

The Building Materials segment drove the revenue beat, with sales increasing 8.2% to $2,445 million. This growth was underpinned by a 5.0% rise in cement volumes and a 6.5% increase in aggregates volumes. Aggregates pricing grew 4.0% on a constant currency, freight-adjusted basis, while cement pricing remained flat at an average selling price of $171.43 per ton. Segment Adjusted EBITDA for Building Materials rose 5.2% to $793 million, aided by ASPIRE savings, though partially offset by higher freight and diesel costs.

Conversely, the Building Envelope segment saw revenues grow 9.4% to $1,049 million due to above-market volume growth in commercial and residential roofing. However, Segment Adjusted EBITDA declined 5.2% to $237 million, reflecting the strain from higher raw material and freight expenses. Jenisch noted that pricing improvements phased in sequentially from the first quarter.

What the Numbers Show

The primary driver behind the earnings miss is the lag between price realization and cost inflation. While revenues surged, Adjusted EBITDA margin contracted by 80 basis points to 28.2%, down from 29.0% in the prior year. This compression underscores the immediate impact of oil-price-driven increases in freight, diesel, and raw materials. Although organic growth remained strong at 6.7%, the margin contraction indicates that cost headwinds are currently outpacing pricing power, particularly in the Building Envelope segment.

Guidance and Capital Allocation

Amrize raised its full-year 2026 revenue guidance to a range of $12.5 billion to $12.7 billion, citing sustained demand. However, it lowered its Adjusted EBITDA guidance to $3.1 billion to $3.2 billion, reflecting persistent cost inflation. The company expects to achieve $80 million in savings through its ASPIRE program in 2026.

Cash flow remained tight, with free cash flow showing a use of $986 million for the six months ended June 30, 2026, up from a use of $860 million in the same period last year. This was driven by higher capital expenditures of $511 million for growth initiatives. Gross debt stood at $6,004 million, resulting in a net leverage ratio of 1.7x as of June 30, 2026. A dividend of $0.11 per share was declared, payable on August 26, 2026, with a record date of August 18, 2026.

Amrize (NYSE: AMRZ) has raised its sales guidance for FY2026, signaling strong confidence in its revenue trajectory amid evolving market conditions. The company updated its full-year sales outlook from a previous range of $12.290 billion to $12.520 billion to a higher band of $12.500 billion to $12.700 billion. This revision is particularly notable as it exceeds the consensus market estimate of $12.464 billion, suggesting that Amrize anticipates better-than-expected demand or pricing power in its core segments.

The upward revision reflects management’s assessment of current order flows and macroeconomic indicators. By lifting both the floor and the ceiling of its guidance, Amrize indicates a broader range of potential outcomes while maintaining a bullish stance on its top-line performance. The new lower bound of $12.500 billion already surpasses the prior upper limit of $12.520 billion by a narrow margin, but the significant expansion of the upper bound to $12.700 billion highlights potential upside scenarios that were not fully priced in previously.

Guidance Revision Details

The decision to raise guidance often stems from improved visibility into customer contracts, successful product launches, or favorable shifts in supply chain dynamics. For investors, this update serves as a key indicator of the company’s operational health and strategic positioning. The fact that the entire new range sits above the analyst estimate suggests that Amrize’s internal models are projecting stronger performance than the broader sell-side consensus.

What the Numbers Show

The most critical aspect of this guidance update is the shift in the midpoint of the sales range. The previous midpoint was approximately $12.405 billion, while the new midpoint stands at $12.600 billion. This represents a meaningful upward adjustment in expected revenue. Furthermore, the new lower bound of $12.500 billion provides a higher safety net for investors compared to the prior $12.290 billion floor. This reduction in downside risk, coupled with an expanded upside potential up to $12.700 billion, underscores a positive inflection point in Amrize’s business outlook for FY2026.